Your session is about to expire
← Back to Search
Hormone Therapy
Hormone Therapy for Transgender Individuals
Phase < 1
Recruiting
Led By Devjit Tripathy, MD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Stable hormone treatment (estrogen or testosterone) for at least 6 months
Healthy volunteers: healthy male or female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months
Awards & highlights
Study Summary
This trial will study the effects of estrogen and testosterone therapy on insulin sensitivity and beta cell function in transgender people.
Who is the study for?
This trial is for transgender individuals who have been on stable hormone therapy (estrogen or testosterone) for at least 6 months and do not have diabetes. Healthy male and female volunteers can also participate, provided they are not currently treated with hormones.Check my eligibility
What is being tested?
The study examines the effects of estrogen in transwomen on insulin sensitivity and immune response, as well as the impact of testosterone in transmen on glucose metabolism. It involves a Botnia Clamp procedure and temporary withdrawal from Gender Affirming Hormone Therapy.See study design
What are the potential side effects?
Potential side effects may include changes in blood sugar levels due to hormone therapy adjustment. The Botnia Clamp might cause discomfort where it attaches to the body.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been on a stable hormone treatment for at least 6 months.
Select...
I am a healthy individual.
Select...
I am a transgender woman.
Select...
I am not diabetic with normal blood sugar levels.
Select...
I am a female-to-male transgender individual.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effects of Chronic estrogen therapy on insulin secretion
Effects of Chronic estrogen therapy on insulin sensitivity
Effects of Chronic testosterone therapy on insulin secretion
+1 moreSecondary outcome measures
Immune response change
Trial Design
4Treatment groups
Active Control
Group I: Healthy Volunteer MaleActive Control1 Intervention
Healthy male currently on no testosterone treatment
Group II: Healthy Volunteer FemaleActive Control1 Intervention
Healthy female currently on no estrogen treatment
Group III: MTF groupActive Control2 Interventions
MTF transgender currently on estrogen treatment
Group IV: FTM groupActive Control2 Interventions
FTM transgender group currently on testosterone treatment
Find a Location
Who is running the clinical trial?
Foundation for advancing Veterans Health Research (FAVHR)AMBIG
Foundation for Advancing Veterans' Health ResearchOTHER
1 Previous Clinical Trials
146 Total Patients Enrolled
The University of Texas Health Science Center at San AntonioLead Sponsor
454 Previous Clinical Trials
90,716 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been on a stable hormone treatment for at least 6 months.I am not currently taking estrogen or testosterone.I am a healthy individual.I am a transgender person with less than 6 months on stable hormone therapy.I have anemia with low hemoglobin and kidney function.I am a transgender woman.I am not diabetic with normal blood sugar levels.I have been diagnosed with diabetes.I am FTM transgender and have not had a recent heart attack or stroke.I am a female-to-male transgender individual.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy Volunteer Male
- Group 2: Healthy Volunteer Female
- Group 3: MTF group
- Group 4: FTM group
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Transgender Patient Testimony for trial: Trial Name: NCT04515472 — Phase < 1
Share this study with friends
Copy Link
Messenger